OR WAIT null SECS
November 20, 2024
SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.
November 19, 2024
Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.
November 01, 2024
The Mobius ADC Reactor is the first single-use reactor designed specifically for the manufacture of antibody drug conjugates.
August 01, 2024
Syngene’s protein production platform uses a cell line and transposon-based technology licensed from Switzerland-based ExcellGene.
July 25, 2024
Univercells and the University of Pennsylvania are expanding their collaboration to evaluate certain bioreactors with the aim to scale up gene therapy manufacturing.
June 12, 2024
The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.
May 02, 2024
Global product manager at Cytiva, Eric Corti, discusses the challenges with designing a new single-use mixing system that ensures leak-free fluid handling operations at INTERPHEX 2024.
April 26, 2024
A tidal wave of questions floats the need for more upstream automation.
December 11, 2023
Pharmaceutical Technology Europe® spoke with Fiona Bellot, sales director, Cellexus BioreactorSystems, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.
August 22, 2023
Sartorius’ Biostat STR now incorporates Repligen’s XCell ATF hardware.